According to our new market research study on “Asia Pacific Patient Controlled Injectors Market to 2027 – Regional Analysis and Forecast – by Product, Application, and Distribution Channel” the market is expected to reach US$ 1,637.74 million by 2027 from US$ 621.47 million in 2019; it is estimated to grow at a CAGR of 12.9% from 2020 to 2027. The report provides trends prevailing in the Asia Pacific patient controlled injectors market and the factors driving the market growth along with those hindering it.

In 2019, the electronic injector segment accounted for the largest market share of the patient controlled injectors market. electronic injector offers benefits like comfort, water resistance, flexible dosing, and automatic warming of refrigerated drug and easy to use. These benefits have increased the demand for electronic injector. Moreover, the mechanical injector segment is expected grow at a faster pace during the forecast period as it eliminates the risks of skin fitting issues, and allergic skin reactions.

The growth of the Asia Pacific patient controlled injectors market is mainly attributed to increasing chronic diseases prevalence, and conventional drug delivery system limitations. However, lack of adoption of patient controlled injectors in emerging countries will restrict the market growth.

Johnson and Johnson Services, Inc.; Sensile Medical AG (Gerresheimer AG), F. HOFFMANN-LA ROCHE LTD, Ypsomed AG, and Westbourne Medical Limited; are among the leading companies operating in the Asia Pacific patient controlled injectors market.

The Report Segments Asia Pacific Patient Controlled Injectors Market as Follows:

Asia Pacific Patient Controlled Injectors Market – By Product

• Electronic Injector
• Mechanical Injector
• Infusion Pumps

Asia Pacific Patient Controlled Injectors Market – By Application

• Cancer Treatment
• Auto-immune Treatment
• Blood Disorders Treatment
• Others

Asia Pacific Patient Controlled Injectors Market – By Distribution Channel

• Hospital Pharmacies
• Retail Pharmacies
• Mail Order Pharmacies

Asia Pacific Patient Controlled Injectors Market – By Country

• Asia Pacific

• • China
  • Japan
  • India
  • South Korea
  • Australia
  • Rest of Asia Pacific